MHRA Class 4 Drug Alert – Memantine 10mg tablets (Crescent Pharma Ltd)

MHRA Class 4 Drug Alert – Memantine 10mg tablets (Crescent Pharma Ltd)

February 25, 2020

Drug alert number: EL (20)A/11

Date issued: 25 February 2020

The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 pharmacy level caution in use for:

Memantine 10mg Film-Coated Tablets (Crescent Pharma Ltd) PL 20416/0260

Crescent Pharma Ltd has informed MHRA of a discrepancy on the product packaging for the batches below. The discrepancy relates to the incorrect quantity printed on one side (end flap) of the packs in error. The incorrect end flap states the quantity as 30, this is incorrect and should state 28 as per all other sides of the pack. All other details on the packaging are correct.


Batch Number Expiry Date Pack Size
10819 08/2022 28
20819 08/2022 28
11119 11/2022 28


Advice for pharmacy teams

When dispensing this product, pharmacy teams are advised to exercise caution, there is no risk to product quality as a result of this issue, therefore the associated batches are not being recalled at this time.

For more information or medical information queries, please contact: Crescent Pharma Ltd Medical Information Department on 01256 772740.

Full details of the drug alert can be viewed here.




Posted in:

More Latest News >

Funding for Easter opening hours

Further to NHS England and NHS Improvement’s (NHSE&I) decision that community pharmacies in England must open between 2pm and 5pm...